Home
Orna Therapeutics

Orna Therapeutics Market Share Analysis for November 2025

orna therapeutics is leaving linear thinking behind to create fully engineered circular rna (orna) therapeutics – an entirely new class of rna medicines.

Health > Biotechnology and Pharmaceuticals

Domainornatx.com

Year Founded2019

Employees51 - 200

Annual Revenue$25M - $50M

Orna Therapeutics

Orna Therapeutics (including company regionals)

ornatx.com

See more website traffic and engagement information

Orna Therapeutics Revenue up to November 2025 is 25M - 50M

revenue generated by Orna Therapeutics top domains

Orna Therapeutics top domains revenue over 3 years

Revenue for Orna Therapeutics top domains

ornatx.com25M - 50M

See more with Sales Intelligence

Total visits to Orna Therapeutics's top domains

Understand Orna Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

ornatx.com3.8K

See more with Sales Intelligence

Avg. visit duration in Orna Therapeutics's top domains

Analyze Orna Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

ornatx.com00:00:29

See more with Sales Intelligence

Avg. pageviews on Orna Therapeutics's top domains

See how Orna Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

ornatx.com1.57

See more with Sales Intelligence

Orna Therapeutics top competitors by domain

Top similar sites in November 2025, ranked by their affinity

dynotx.comCompany NameDyno TherapeuticsEmployees51 - 200HQUnited States, Massachusetts, CambridgeAnnual revenue$2M - $5MTotal visits11KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Orna Therapeutics

These are the website technologies, by industry, used by Orna Therapeutics top domains

Payment & Currencies (10)

Cart Functionality

Advertising (5)

Google Adsense

eCommerce (5)

OpenCart

Cryptocurrency (2)

Bitcoin Acceptance

More Technologies

11

See all

News & Signals from Orna Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsOrna Therapeutics, Inc. attended event 67th American Society of Hematology (ASH) Annual Meeting on Dec 6th '25.WATERTOWN, Mass., Dec. 7, 2025 - Orna Therapeutics (Orna), a biotechnology company dedicated to engineering immune cells in vivo to treat autoimmune and oncology diseases, today announced new preclinical data supporting the Company's in vivo CAR programs to target and treat a broad range of B cell-mediated autoimmune diseases and plasma cell or BCMA-related diseases at the 67th American Society of Hematology (ASH) Annual Meeting taking place in Orlando, Florida from December 6-9, 2025.

NewsOrna Therapeutics, Inc. invests into assets: RNA delivery technology.ReNAgade Therapeutics also delivered a strategic exit when Orna Therapeutics acquired its RNA delivery technology in mid-2024.

NewsOrna Therapeutics, Inc. is developing RNA-based therapies in multiple myeloma.Orna Therapeutics and Shanghai Simnova have announced an expansion of their strategic collaboration to develop RNA-based therapies in multiple myeloma.